On 05 March 2026, BeiGene (06160) published its Monthly Return for the period ended 28 February 2026. The authorized share capital remained unchanged at 2,311,463,847 shares, each with a nominal value of US$0.0001, aggregating to US$231,146.38. No increases or decreases in issued or treasury shares were recorded, leaving the total issued share count at 1,425,622,549.
The public float continues to meet regulatory requirements. A separate pool of 115.06 million RMB shares listed on the Shanghai Stock Exchange remains unaffected. In February, 729,963 share options were canceled under the Fourth Amended and Restated 2016 Share Option and Incentive Plan, reducing outstanding options to 29.02 million. While no new shares were issued during the month, a total of US$6.16 million was raised from exercised share options. The total number of shares that may be issued or transferred upon further exercise of share options stands at 61.80 million.
Comments